Abstract
7565 Background: MPM is an aggressive disease with poor prognosis and is relatively refractory to currently available therapies. CRS-207 is live-attenuated Listeria monocytogenes engineered to expr...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
